NASP Submits Comments on CMS’ Proposed 340B Payment Changes
Sep 01 · Advocacy
NASP submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the CY 2027 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule. The comments focus on proposed changes to Medicare reimbursement for 340B-acquired drugs and the data used to inform the proposed payment methodology. NASP also addresses the operational, dispensing, and compliance considerations associated with administering a 340B program and the potential implications of these policies for specialty pharmacy services and preserving patient access.